Availability of Local Therapy to Castration-Resistant Prostate Cancer for M0 Patients with Initial Prostate Specific Antigen 100 ng/ml or Higher

Prostate cancer patients with initial PSA 100 ng/ml or greater who received transrectal ultrasoundguided prostate biopsy and were staged as M0 by imaging studies from 2011 to 2014 in seven hospitals, were enrolled in the study. Castration-resistant prostate cancer (CRPC)-free survival was compared b...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 12 vom: 31. Dez., Seite 515-520
1. Verfasser: Kuromoto, Akito (VerfasserIn)
Weitere Verfasser: Tanaka, Takaki, Koyama, Juntaro, Goto, Takuro, Kimura, Shingo, Katsumata, Yuki, Myoen, Shingo, Ozawa, Michinobu, Morozumi, Kento, Sato, Masahiko, Hoshi, Senji, Numahata, Kenji, Arai, Yoichi
Format: Online-Aufsatz
Sprache:Japanese
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Multicenter Study Prostate-Specific Antigen EC 3.4.21.77